RAR selective agonists in combination with immune modulators for cancer immunotherapy
Abstract:
Disclosed herein are methods for treating cancer comprising administering CAR-modified immune cells and at least one Retinoic Acid Receptor agonist.
Information query
Patent Agency Ranking
0/0